ROBERT VENUTI: Open Payments
NPI 1548274442 · TURNERSVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,633 in 23 payments from 11 companies in 2025. Trend: 2023 $2,818 · 2024 $1,397 · 2025 $1,633
Food & beverage: $1,633
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $453 |
| Novo Nordisk Inc | 4 | $280 |
| Amgen Inc. | 7 | $213 |
| Otsuka America Pharmaceutical, Inc. | 1 | $133 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $117 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $92 |
| Phathom Pharmaceuticals, Inc. | 1 | $92 |
| ABIOMED | 1 | $81 |
| Axsome Therapeutics, Inc. | 1 | $76 |
| AstraZeneca Pharmaceuticals LP | 1 | $76 |
Products named: VRAYLAR, OTEZLA, Ozempic, Wegovy, REXULTI, QULIPTA, Kerendia, JARDIANCE.
Industry payments across NJ — which companies pay providers there.
